Murdaca et al. pointed out the importance of pharmacogenomics in the choice of tailored biologics as TNF-alpha inhibitors in psoriatic arthritis (Murdaca et al., 2014a,b). The gene discussed is TNF; the disease is psoriatic arthritis.